BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
69.60
+1.06 (1.55%)
Mar 23, 2026, 4:00 PM EDT - Market closed
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $13.49 billion as of March 24, 2026. Its market cap has increased by 124.72% in one year.
Market Cap
13.49B
Enterprise Value
14.77B
1-Year Change
124.72%
Ranking
Category
Stock Price
$69.60
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $13.49B, an increase of 306.44%. That is a compound annual growth rate of 23.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 13.49B | -8.46% |
| Dec 31, 2025 | 14.74B | 184.24% |
| Dec 31, 2024 | 5.19B | -26.16% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 18.98B |
| Incyte | 18.07B |
| Genmab | 15.55B |
| Ascendis Pharma | 13.62B |
| Summit Therapeutics | 12.03B |
| Ionis Pharmaceuticals | 11.73B |
| Jazz Pharmaceuticals | 11.12B |
| Exelixis | 10.72B |